Antibodies for use in antilymphocyte antibody therapy
US5183657A · kind A · utility
45Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 7, 1992 |
| Grant date | Feb 2, 1993 |
| Priority date | — |
| Expiry date | May 7, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of antibodies against human alpha tumor necrosis factor in antilymphocyte antibody therapy is described. The anti-human alpha tumor necrosis factor antibodies may be used to prevent or treat shock-related conditions arising from antilymphocyte antibody therapy. Also described are compositions containing anti-human alpha tumor necrosis factor antibodies and antilymphocyte antibodies, as well as recombinant anti-human alpha tumor necrosis factor antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.